aTyr Pharma, Inc. (NASDAQ:LIFE) Given Average Rating of "Moderate Buy" by Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pale Fire Capital SE bought a new stake in aTyr Pharma, Inc. (NASDAQ:LIFE – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 55,857 shares of the biotechnology company’s stock, valued at approximately $88,000. Pale Fire Capital […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the target of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 99,400 shares, a decrease of 44.0% from the January 15th total of 177,500 shares. Based on an average daily trading volume, of 399,300 […]
Shares of aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price […]